Feedback / Questions
vanucizumab (RG7221) - Roche
Roche: Analyst Event at ASCO 2016
(Roche)
-
Jun 11, 2016 -
Anticipated data from P2 McCAVE trial (NCT02141295) of vanucizumab in combination with FOLFOX in 1L mCRC in late 2016
Anticipated P2 data
•
Colorectal Cancer • Oncology
http://www.roche.com/irp20160605.pdf
Jun 11, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious